239 related articles for article (PubMed ID: 27142127)
1. Intestinal Behçet's disease with pyoderma gangrenosum successfully treated with the combination therapy of adalimumab and glucocorticoids.
Kashiwado Y; Uchino A; Ota T; Nagano S
Mod Rheumatol; 2018 Sep; 28(5):901-905. PubMed ID: 27142127
[TBL] [Abstract][Full Text] [Related]
2. Vegetative pyoderma gangrenosum in Behçet's disease.
Kim JW; Park JH; Lee D; Hwang SW; Park SW
Acta Derm Venereol; 2007; 87(4):365-7. PubMed ID: 17598044
[No Abstract] [Full Text] [Related]
3. [Pyoderma gangrenosum and Behçet's disease: a study of two pediatric cases].
Hali F; Khadir K; Chiheb S; Bouayad K; Mikou N; Benchikhi H
Arch Pediatr; 2011 Dec; 18(12):1320-3. PubMed ID: 22030347
[TBL] [Abstract][Full Text] [Related]
4. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
Kim DW; Lee BI; Park SH
Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
[TBL] [Abstract][Full Text] [Related]
5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Behcet's disease with pyoderma gangrenosum: a case report.
Nakamura T; Yagi H; Kurachi K; Suzuki S; Konno H
World J Gastroenterol; 2006 Feb; 12(6):979-81. PubMed ID: 16521233
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
[TBL] [Abstract][Full Text] [Related]
8. Behçet's syndrome with pyoderma-gangrenosum-like lesions treated successfully with dapsone monotherapy.
Joshi A; Mamta
J Dermatol; 2004 Oct; 31(10):806-10. PubMed ID: 15672708
[TBL] [Abstract][Full Text] [Related]
9. Successful Use of Adalimumab for Treating Pyoderma Gangrenosum with Ulcerative Colitis under Corticosteroid-tapering Conditions.
Sagami S; Ueno Y; Tanaka S; Nagai K; Hayashi R; Chayama K
Intern Med; 2015; 54(17):2167-72. PubMed ID: 26328641
[TBL] [Abstract][Full Text] [Related]
10. Topical Management of Peristomal Pyoderma Gangrenosum: A Report of 3 Case Studies.
Toyoda T; Mitsuyama S; Nagao E; Abe F; Kimura M; Seido Y; Higuchi T
J Wound Ostomy Continence Nurs; 2021 Jul-Aug 01; 48(4):345-349. PubMed ID: 33951706
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
Sawka E; Zhou A; Latour E; Friedman M; Ortega-Loayza AG
Clin Rheumatol; 2021 Oct; 40(10):3963-3969. PubMed ID: 34002351
[TBL] [Abstract][Full Text] [Related]
12. Neutrophilic dermatosis and hidradenitis suppurativa in patients with Behçet's disease: A neutrophilic disease in the spectrum of autoinflammatory syndromes.
Bugaut H; Barete S; Bagot M; Bouaziz JD; Le Pelletier de Glatigny F; Gallien Y; Biard L; Domont F; Cacoub P; Saadoun D; Comarmond C
Semin Arthritis Rheum; 2023 Aug; 61():152224. PubMed ID: 37207416
[TBL] [Abstract][Full Text] [Related]
13. Adalimumab in the treatment of pediatric Behçet's disease: case-based review.
Poddighe D; Mukusheva Z; Dauyey K; Assylbekova M
Rheumatol Int; 2019 Jun; 39(6):1107-1112. PubMed ID: 30976833
[TBL] [Abstract][Full Text] [Related]
14. Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature.
Campanati A; Brisigotti V; Ganzetti G; Molinelli E; Giuliodori K; Consales V; Racchini S; Bendia E; Offidani A
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1245-7. PubMed ID: 25200926
[No Abstract] [Full Text] [Related]
15. Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet's disease.
Kim HJ; Kim KT; Lee SG; Kim Y
Z Rheumatol; 2020 Sep; 79(7):702-706. PubMed ID: 32494950
[TBL] [Abstract][Full Text] [Related]
16. Atypical Behçet's disease with peripheral erosive arthropathy and pyoderma gangrenosum.
Armas JB; Davies J; Davis M; Lovell C; McHugh N
Clin Exp Rheumatol; 1992; 10(2):177-80. PubMed ID: 1505112
[TBL] [Abstract][Full Text] [Related]
17. Nonspecific genital ulcers.
Sehgal VN; Pandhi D; Khurana A
Clin Dermatol; 2014; 32(2):259-74. PubMed ID: 24559562
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
[TBL] [Abstract][Full Text] [Related]
19. Marked improvement in gastric involvement in Behçet's disease with adalimumab treatment.
Sonoda A; Ogawa R; Mizukami K; Fukuda K; Shuto M; Okamoto K; Matsunari O; Okimoto T; Murakami K
Turk J Gastroenterol; 2017 Sep; 28(5):405-407. PubMed ID: 28797990
[TBL] [Abstract][Full Text] [Related]
20. Case of pyoderma gangrenosum showing oral and genital ulcers, misdiagnosed as Behcet's disease at first medical examination.
Tsuboi H
J Dermatol; 2008 May; 35(5):289-92. PubMed ID: 18477229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
